Compound 1557
Identifiers
- Canonical SMILES:
CC(C)C[C@H]1N[C@H]([C@H](c2ccc(Cl)cc2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)N(C)C
- IUPAC name:
(2'R,3S,3'R,5'R)-6-chloro-3'-(4-chlorophenyl)-N,N-dimethyl-5'-(2-methylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C24H27Cl2N3O2/c1-13(2)11-19-24(17-10-9-16(26)12-18(17)27-23(24)31)20(14-5-7-15(25)8-6-14)21(28-19)22(30)29(3)4/h5-10,12-13,19-21,28H,11H2,1-4H3,(H,27,31)/t19-,20+,21-,24+/m1/s1
- InChiKey:
CIAKKMIXEZWILV-WHLIWEHUSA-N
External links
![]() 11340134 |
![]() 9515077 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 3 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.17 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 459.15 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 4.45 | |||
TPSA | 61.44 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 3 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
16028899 | 1c | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.11 | |
16028899 | 1c | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | LNCaP cells | pIC50 (half maximal inhibitory concentration, -log10) | 5.17 |
16028899 | 1c | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | PC-3 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.64 |
16028899 | 1c | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | PrEC cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.66 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8171 | SAR-405838 | DB12541 | |
0.6505 | Milademetan | DB15257 | |
0.5901 | Mosapramine | DB13676 | |
0.5775 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5775 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.5625 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | DB02058 | |
0.5588 | SLV-334 | DB15356 | |
0.5563 | Amedalin | DB09188 | |
0.5515 | OPC-51803 | DB05838 | |
0.5454 | Degarelix | DB06699 | |
0.5398 | Daglutril | DB05796 | |
0.5357 | OPC-14523 | DB05422 | |
0.5357 | Lorcainide | DB13653 | |
0.5305 | Benazeprilat | DB14125 | |
0.5222 | Acyline | DB11906 |